What AI says about SpringWorks Therapeutics

SpringWorks Therapeutics is a biopharmaceutical company focused on developing targeted oncology treatments for rare cancers and devastating diseases. The company's late-stage programs include OGSIVEO (nirogacestat) for desmoid tumors and EZMEKLY (mirdametinib) for NF1-related plexiform neurofibromas, with ongoing research into BCMA combination therapies for multiple myeloma.